Take Solutions, the intensive technology player in the Life Sciences space, is leveraging the strong growth in the life sciences and biotech domain effectively so far - the company reported a 38.4% growth in net incomes to Rs 343.05 crore, and a 34.3% rise in profits for its third quarter, compared to the same period last year. 

The company's recent growth in clinical services has been helped by a patent around clinical data standards in the US. It remains to be seen if the company's global services to pharma and biotech companies will be impacted by the new orders planned by the US administration against H1B, and tech/pharma imports.